GLP-1 medications have become some of the most talked-about treatments for weight loss and blood sugar management. Popular medications like Ozempic®, Wegovy®, Mounjaro®, and Zepbound® have helped millions of people manage obesity and type 2 diabetes more effectively.
Most FDA-approved GLP-1 medications are available either as a once-weekly injection or a traditional oral tablet that is swallowed whole.
Recently, however, more people have started searching for alternatives like ‘sublingual semaglutide’ or ‘under-the-tongue GLP-1 drops.’ If you’ve seen these products online, it’s important to understand what they actually are and how they differ from FDA-approved medications.
What Are Sublingual GLP-1 Medications?
At this time, there are no FDA-approved sublingual versions of semaglutide or tirzepatide.
Products marketed as ‘sublingual GLP-1 medications’ are typically compounded formulations created by specialty compounding pharmacies. These are custom-made preparations designed to dissolve under the tongue before being swallowed.
The idea behind sublingual delivery is simple: many patients dislike injections or struggle with the strict fasting requirements associated with some oral GLP-1 medications. Compounding pharmacies have attempted to create needle-free alternatives that may feel more convenient and easier to use.
These products are often sold as liquid drops, dissolvable tablets, or under-the-tongue suspensions. Most instructions recommend holding the medication under the tongue for around 90 to 120 seconds before swallowing.
Why Sublingual GLP-1 Medications Are Controversial
No FDA Approval
Currently, the FDA has not approved any sublingual form of semaglutide or tirzepatide. That means these formulations have not gone through the same level of clinical testing for safety, absorption, dosing consistency, or long-term effectiveness as approved GLP-1 medications.
Absorption Challenges
One of the biggest concerns is how well these medications are actually absorbed.
GLP-1 medications like semaglutide and tirzepatide are large peptide molecules. The tissue under the tongue absorbs small molecules very efficiently, but larger protein-based compounds are generally much harder for the body to absorb consistently through this route.
Because of that, experts continue to question whether sublingual versions deliver reliable medication levels into the bloodstream.
Limited Clinical Research
There are currently no large-scale, peer-reviewed clinical trials showing that sublingual GLP-1 products produce the same weight loss or blood sugar results seen with FDA-approved injections or oral tablets.
Results may vary significantly from person to person based on factors like saliva production, how long the medication is held under the tongue, individual absorption differences, and formulation quality from the compounding pharmacy.
FDA-Approved Needle-Free GLP-1 Alternatives
Rybelsus®
Rybelsus® is an oral form of semaglutide taken once daily. It uses a specialized absorption technology that helps protect the medication as it passes through the stomach.
To work properly, it must be taken on an empty stomach, with a small amount of water, and at least 30 minutes before eating or drinking anything else.
Orforglipron (Foundayo™)
Orforglipron is a newer oral GLP-1 medication developed as a small-molecule drug rather than a peptide. Unlike traditional semaglutide tablets, it does not require strict fasting rules and may offer more flexibility for patients seeking a convenient daily oral option.
Should You Consider Sublingual Semaglutide?
Sublingual GLP-1 medications may appeal to people who want to avoid injections, but it’s important to understand that these products are still largely unproven compared to FDA-approved options.
If you are considering compounded semaglutide or tirzepatide products, work with a reputable, licensed compounding pharmacy, discuss risks and expectations with your healthcare provider, and understand that absorption and effectiveness may vary.
As research continues, more needle-free GLP-1 options will likely become available. For now, FDA-approved injectable and oral medications remain the most studied and reliable choices for weight loss and diabetes management.
